Neuroendovascular Coil Market Size & Growth Forecast 2027–2036, By Segments (Type, Application, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Neuroendovascular Coil Market size was estimated at USD 1.16 billion in 2026 and is projected to grow at a 6.89% CAGR from 2027 to 2036, exceeding USD 2.26 billion by 2036. The industry revenue for 2027 is calculated at USD 1.23 billion.
Get more details on this report
Request Free Sample ReportNeuroendovascular Coil Market Intelligence Snapshot
Regional Market Dynamics
- North America accounts for 39.65% of the market, benefiting from specialized neurovascular centers, advanced imaging technologies, experienced clinical professionals, and growing adoption of minimally invasive intracranial aneurysm treatments.
- Asia Pacific is expected to grow fastest as hospital infrastructure improves, neurovascular awareness increases, and investments in specialized neurological care, physician training, and minimally invasive procedures expand treatment access.
Segment Momentum
- Bare platinum coils held 54.38% of the market in 2026, supported by their established use in intracranial aneurysm treatment, radiopacity, and compatibility with minimally invasive catheter-based procedures. Familiarity among specialists and varied device configurations reinforce adoption.
- Hydrogel-coated coils are the fastest-growing type segment, driven by interest in improved aneurysm filling and effective embolization. Their expansion after deployment can increase packing density, supporting interest in advanced devices designed to improve treatment outcomes.
Market Expansion Drivers
- Rising prevalence of neurovascular disorders.
- Technological advancements in coil design and materials.
- Expansion of neuroendovascular procedures in emerging regions.
Leading Market Participants
- Leading players in the neuroendovascular coil market include Stryker (USA), Medtronic (Ireland), Terumo (Japan), Penumbra (USA), MicroVention (USA), Balt (France), Cook Medical (USA), Johnson & Johnson (USA), Phenox (Germany), Acandis (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.16 billion
- 2027 Estimated Market Size: USD 1.23 billion
- Projected Market Size: USD 2.26 billion by 2036
- Growth Forecast: 6.89% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Type (Bare Platinum Coils) | Application (Cerebral Aneurysm) | End Use (Hospitals)
- Emerging Opportunity Segment: Type (Hydrogel-Coated Coils) | Application (Arteriovenous Malformation (AVM)) | End Use (Hospitals)
Market Growth Drivers and Industry Trends
Rising prevalence of neurovascular disorders
The rising prevalence of neurovascular disorders is driving demand for neuroendovascular coils as healthcare providers increasingly require minimally invasive treatment options for conditions such as intracranial aneurysms and other vascular abnormalities. Growing awareness of neurovascular conditions, improvements in diagnostic capabilities, and increased emphasis on early intervention are supporting the identification and treatment of patients requiring endovascular procedures. The preference for minimally invasive approaches that can reduce surgical trauma and support faster recovery is further contributing to the adoption of coil-based interventions in neurovascular care.
Technological advancements in coil design and materials
Technological advancements in coil design and materials are supporting market growth by improving the effectiveness, flexibility, deliverability, and procedural control of neuroendovascular devices. Innovations in coil structure, surface characteristics, material composition, and deployment mechanisms are enabling physicians to address complex vascular anatomies and improve the management of intracranial aneurysms. Continued development of more sophisticated coil technologies is also supporting enhanced procedural precision and expanding the applicability of endovascular treatment across a broader range of neurovascular cases.
Expansion of neuroendovascular procedures in emerging regions
The expansion of neuroendovascular procedures in emerging regions is creating new opportunities for the neuroendovascular coil market as healthcare systems strengthen specialized neurological care and increase access to minimally invasive interventions. Improvements in hospital infrastructure, growing availability of advanced imaging technologies, and increasing training of neurointerventional specialists are supporting the development of neuroendovascular capabilities. Rising awareness of minimally invasive treatment options and investments in specialized healthcare facilities are further encouraging the adoption of coil-based procedures across developing healthcare markets.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of neurovascular disorders | 2.5% | Short term (≤ 2 yrs) | North America; Europe | High | Fast |
| Technological advancements in coil design and materials | 2.3% | Medium term (2–5 yrs) | Europe; Asia Pacific | Medium | Moderate |
| Expansion of neuroendovascular procedures in emerging regions | 2% | Long term (5+ yrs) | Asia Pacific; Latin America | Medium | Moderate |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
The North America neuroendovascular coil market held a 39.65% share in 2026, driven by advanced healthcare infrastructure, growing demand for minimally invasive neurovascular procedures, and increasing adoption of interventional approaches for the treatment of intracranial aneurysms. The region benefits from specialized neurovascular centers, experienced clinical professionals, and access to advanced imaging and endovascular technologies. Rising awareness of minimally invasive treatment options, improvements in procedural techniques, and continued innovation in neurointerventional devices are supporting market development. Increasing investments in specialized neurological care and expanding access to advanced treatment modalities are further contributing to regional demand.
Asia Pacific (Fastest-Growing Region)
The Asia Pacific neuroendovascular coil market is expected to grow at the fastest rate during the forecast period, supported by improving healthcare infrastructure, rising awareness of neurovascular disorders, and expanding access to minimally invasive treatment options. Growing investments in advanced hospitals and specialized neurological care are increasing the availability of endovascular procedures. The rising burden of cerebrovascular conditions, improvements in diagnostic capabilities, and increasing adoption of modern interventional techniques are creating significant opportunities for neuroendovascular coils. Greater physician training and expanding access to specialized treatment centers are also expected to support market expansion across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Advanced Coil-Based InterventionThe U.S. market prioritizes advanced endovascular treatment options for intracranial aneurysms, with clinical practice emphasizing device performance, procedural flexibility, and evidence-supported adoption. Neurointerventional centers are likely to focus on coil technologies that complement evolving embolization strategies and enable tailored treatment across complex aneurysm anatomies.
Germany 🇩🇪
Evidence-Based Aneurysm TreatmentGermany’s neuroendovascular coil market is shaped by emphasis on clinical evidence, procedural safety, and disciplined technology adoption. Hospitals and specialists are likely to evaluate coil systems based on deliverability, occlusion performance, compatibility with adjunctive devices, and their fit within established neurointerventional treatment pathways.
Japan 🇯🇵
Precision NeurointerventionJapan places particular importance on procedural precision and dependable device handling in neuroendovascular care. Coil technologies supporting controlled deployment, accurate positioning, and treatment of anatomically challenging aneurysms are commercially relevant as specialists seek to balance procedural efficacy with established clinical protocols.
South Korea 🇰🇷
Technology-Driven Aneurysm CareSouth Korea’s neuroendovascular priorities center on sophisticated intervention capabilities and efficient procedural execution. Hospitals can favor coil systems offering predictable delivery, flexible sizing, and compatibility with adjunctive techniques, particularly where neurointerventional teams manage anatomically complex aneurysms and seek refined treatment options.
France 🇫🇷
Specialized Embolization PracticeFrance’s market emphasizes specialist-led neurointerventional treatment and dependable embolization technologies. Coil suppliers can focus on device navigability, controlled deployment, and integration with complementary techniques, while clinical adoption remains closely tied to procedural evidence and the requirements of specialized hospital teams.
Italy 🇮🇹
Hospital-Based Intervention FocusItaly’s neuroendovascular coil priorities are centered on hospital-based specialist care and practical procedural performance. Technologies that provide reliable delivery, a broad range of configurations, and compatibility with established embolization approaches can support neurointerventional teams treating varied intracranial aneurysm presentations.
Neuroendovascular Coil Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Bare Platinum Coils (Largest Segment) vs Hydrogel-Coated Coils (Fastest-Growing Segment)
The bare platinum coils segment captured the largest type share of 54.38% in 2026, supported by their established use in endovascular treatment of intracranial aneurysms and their long-standing role in neurointerventional procedures. Platinum coils provide radiopacity and can be delivered through minimally invasive catheter-based techniques, allowing physicians to visualize and position the device during embolization procedures. Their established clinical use, familiarity among neurointerventional specialists, and availability across different configurations support continued utilization in cerebral aneurysm treatment. Growing adoption of minimally invasive approaches in neurovascular care and increasing diagnosis of intracranial aneurysms are contributing to demand for established coil technologies. In addition, continued improvements in coil design and delivery systems are helping support procedural efficiency and expand their application in endovascular interventions.
The hydrogel-coated coils segment is expected to be the fastest-growing type category, driven by increasing interest in coil technologies designed to enhance aneurysm filling and promote more effective embolization. Hydrogel coatings can expand after deployment, helping increase packing within the aneurysm and potentially supporting more complete occlusion of the targeted vascular lesion. The growing emphasis on improving procedural outcomes and reducing the likelihood of aneurysm recurrence is encouraging interest in advanced embolization technologies. Continued innovation in device materials and coating technologies is also expanding the capabilities of neuroendovascular coils, while increasing adoption of minimally invasive neurovascular procedures is creating additional opportunities for advanced coil designs.
Application Segment Analysis: Cerebral Aneurysm (Largest Segment) vs Arteriovenous Malformation (AVM) (Fastest-Growing Segment)
The cerebral aneurysm segment held the largest 2026 application share, reflecting the established use of neuroendovascular coils for minimally invasive embolization of intracranial aneurysms. Endovascular coiling provides an alternative to open surgical approaches by enabling physicians to access and occlude aneurysms through catheter-based techniques. Growing awareness and diagnosis of cerebral aneurysms, improvements in neuroimaging, and increasing adoption of minimally invasive neurovascular procedures are supporting demand for coil-based interventions. Advances in catheter delivery systems and coil configurations are also helping clinicians address different aneurysm anatomies and procedural requirements, strengthening the role of neuroendovascular coils in cerebral aneurysm management.
The arteriovenous malformation (AVM) segment is expected to be the fastest-growing application category, supported by increasing interest in minimally invasive embolization techniques for managing abnormal connections between arteries and veins in the brain and other neurovascular regions. Endovascular approaches can be used to reduce blood flow through selected portions of an AVM and may form part of a broader treatment strategy. Advances in catheter navigation, embolization technologies, imaging guidance, and procedural planning are improving the ability of clinicians to manage complex vascular abnormalities. Growing adoption of specialized neurointerventional procedures and continued development of technologies designed to address challenging vascular anatomies are expected to support increasing utilization of neuroendovascular devices in AVM-related applications.
End Use Segment Analysis: Hospitals (Largest & Fastest-Growing Segment)
The hospitals segment registered the largest end use share in 2026 and is also expected to be the fastest-growing end-use category in the neuroendovascular coil market. Hospitals provide the specialized infrastructure required for complex neurointerventional procedures, including advanced imaging systems, catheterization facilities, operating environments, and multidisciplinary teams of neurologists, neurosurgeons, radiologists, and other specialists. The increasing adoption of minimally invasive treatment approaches for cerebral aneurysms and other neurovascular conditions is supporting demand for coil-based interventions in hospital settings. Hospitals are also increasingly investing in advanced neurovascular capabilities to provide comprehensive diagnosis and treatment for patients with complex cerebrovascular disorders. Improvements in imaging-guided intervention, specialized clinical expertise, and emergency neurovascular care are further supporting the use of neuroendovascular coils across hospital-based procedures.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Bare Platinum Coils, Hydrogel-Coated Coils | Bare Platinum Coils | Hydrogel-Coated Coils |
| Application | Cerebral Infarction, Cerebral Aneurysm, Arteriovenous Malformation (AVM), Others | Cerebral Aneurysm | Arteriovenous Malformation (AVM) |
| End Use | Hospitals, Ambulatory Surgery Centers, Specialty Clinics, Others | Hospitals | Hospitals |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
Navigating the neuroendovascular coil sector demands meticulous mechanical refinement paired with solid procedural validation. Device makers compete intensely on catheter trackability and low-profile delivery systems, ensuring clinicians can traverse tortuous neurovascular paths to access complex intracranial aneurysms safely. Procedural confidence relies heavily on the engineering of detachment mechanisms, where predictable release and tactile control directly influence physician adoption. While material innovations like hydrogel coatings and bioactive surface modifications aim to improve biological healing, and varied framing-to-packing coil profiles attempt to maximize occlusion density, market leaders distinguish themselves by backing these structural features with clinical evidence that proves long-term stability without compromising device handling.
Major players in the neuroendovascular coil market:
- Stryker (USA)
- Medtronic (Ireland)
- Terumo (Japan)
- Penumbra (USA)
- MicroVention (USA)
- Balt (France)
- Cook Medical (USA)
- Johnson & Johnson (USA)
- Phenox (Germany)
- Acandis (Germany)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Stryker (USA) | |||||||
| Medtronic (Ireland) | |||||||
| Terumo (Japan) | |||||||
| Penumbra (USA) | |||||||
| MicroVention (USA) | |||||||
| Balt (France) | |||||||
| Cook Medical (USA) | |||||||
| Johnson & Johnson (USA) | |||||||
| Phenox (Germany) | |||||||
| Acandis (Germany) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Penumbra | February 2025 | Penumbra introduced the Access25 delivery microcatheter, designed to support access to the neurovasculature for the delivery of the company's 0.020-inch coil platform, enhancing its neurovascular product portfolio and commercial position in minimally invasive treatment segments. |
| Kaneka Corporation | January 2025 | Kaneka Corporation acquired a 96.8 percent stake in EndoStream Medical Ltd. to expand its healthcare business and strengthen its competitive positioning within the neurovascular treatment market, establishing a foundation for joint medical device development focused on cerebrovascular treatments. |
| CERENOVUS, Inc. | May 2023 | CERENOVUS, Inc. executed the U.S. commercial launch of the CEREPAK Detachable Coils alongside successful initial patient cases, expanding the firm's commercialized neurovascular product offerings in clinical settings. |
| Stryker | December 2022 | Stryker secured FDA 510(k) clearance for the Target Tetra Detachable Coil featuring a tetrahedral shape and refined softness for treating small cerebral aneurysms, reinforcing the company's neurovascular portfolio and leadership in complex aneurysm management. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Neuroendovascular Coil Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Detachment Mechanism | Electrolytic Detachment, Mechanical Detachment, Hydraulic Detachment |
| Coiling Technique | Simple Coiling, Balloon-Assisted Coiling, Stent-Assisted Coiling, Other Adjunctive Coiling |
| Distribution Channel | Direct Sales, Medical Device Distributors, Group Purchasing Organizations |
Neuroendovascular Coil Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Procedure Adoption and Physician Preference Dynamics |
|
| Hospital Procurement and Tender Strategies |
|
| Procedure Economics and Hospital Value Drivers |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
What is the total addressable market for neuroendovascular coil?
What is the expected industry size of neuroendovascular coil by 2036?
How are advances in coil design expanding the role of minimally invasive neurovascular treatment?
How is neuroendovascular infrastructure expansion in emerging regions supporting coil adoption?
Why do bare platinum coils lead the neuroendovascular coil market?
What is driving growth in hydrogel-coated neuroendovascular coils?
Why does North America dominate the neuroendovascular coil market?
What is driving the fastest growth in the Asia Pacific neuroendovascular coil market?
Which companies dominate the neuroendovascular coil landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook